Publications

Our Future Health: a unique global resource for discovery and translational research.

Cook MB. et al, (2025), Nat Med, 31, 728 - 730

"Target Trial Emulation" for Observational Studies - Potential and Pitfalls.

Hubbard RA. et al, (2024), N Engl J Med, 391, 1975 - 1977

Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Kentistou KA. et al, (2024), Nat Genet, 56, 1763 - 1764

Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Kentistou KA. et al, (2024), Nat Genet, 56, 1397 - 1411

ssessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Collister JA. et al, (2024), Cancer Epidemiol Biomarkers Prev, 33, 812 - 820

Supplementary Table S8 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S8 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S7 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S9 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Search results (312)

Our Future Health: a unique global resource for discovery and translational research.

"Target Trial Emulation" for Observational Studies - Potential and Pitfalls.

Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

ssessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Supplementary Table S8 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Table S8 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Table S7 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Table 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Table 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Table S9 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Table 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Table 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Leading Human Health Forward

Cookies on this website

Search results (312)

Leading Human Health Forward